National Cardiogenic Shock Initiative Update

Dr. Bill O’Neill Discusses Ongoing Progress in NCSI Bill O’Neill, MD presents some of the overall...

NCSI Findings Regarding Right Ventricular Dysfunction

About 40% of AMICS Patients Develop Right Ventricular Dysfunction Dr. Babar Basir, an interventionalist at Henry Ford...

Multicenter Impella Experience Data from Dr. Andreas Schäfer

Impella for AMI Cardiogenic Shock Dr. Andreas Schäfer, an interventional cardiologist and intensivist from Hannover,...

Duane Pinto Comments on SCAI Vascular Access and Closure Best Practices

A Practical Resource for Practicing Physicians Duane Pinto, MD, MPH, one of the nation’s experts on...

Where’s the Cardiogenic Shock Treatment Data?

Looking to Real-world Evidence in Cardiogenic Shock Dr. William O’Neill discusses...

Clinical Paper: Beyond Reperfusion by Jerry Curran

Acute Ventricular Unloading and Cardioprotection During MI Jerry Curran PhD, Senior Scientist at Abio...

Impella Support Pre-PCI for AMICS is Associated with Higher Survival in Women

Reference: J Interven Cardiol 2016; 29:248–256. Ca...

INOVA Heart and Vascular Heart Recovery Initiative

Instituting a Cardiogenic Shock Protocol to Improve Outcomes Alexander Truesdell, MD and Behnam Tehrani, MD, intervent...

Dr. Bill O’Neill: New Data from NCSI & Improving Outcomes in Cardiogenic Shock

“This is a coalition of the willing…I think all of you have to decide tomorrow when you go home, in your hospit...

The Door-to-Unloading (DTU) STEMI Safety & Feasibility Trial

Navin Kapur, MD, executive director of the CardioVascular Center for Research and Innovation at Tufts Medical Center, discusses...

National Cardiogenic Shock Initiative: 1 Year Later

Video Chapters:The Impact of The Cardiogenic Shock Initiative (NCSI):...

Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device

Dr. William O’Neill outlines his recent publication of 15,529 AMI cardiogenic shock patients from the Impella Quality (IQ) da...